18F-Fluorodeoxyglucose positron emission tomography optimizes neoadjuvant chemotherapy for primary breast cancer to achieve pathological complete response

Shigeto Ueda,Toshiaki Saeki,Takashi Shigekawa,Jiro Omata,Tomoyuki Moriya,Junji Yamamoto,Akihiko Osaki,Nobuko Fujiuchi,Misono Misumi,Hideki Takeuchi,Takaki Sakurai,Hitoshi Tsuda,Katsumi Tamura,Jiro Ishida,Yoshiyuki Abe,Etsuko Imabayashi,Ichiei Kuji,Hiroshi Matsuda

18F-Fluorodeoxyglucose positron emission tomography optimizes neoadjuvant chemotherapy for primary breast cancer to achieve pathological complete response

2012

Shigeto Ueda
Toshiaki Saeki
Takashi Shigekawa
Jiro Omata
Tomoyuki Moriya
Junji Yamamoto
Akihiko Osaki
Nobuko Fujiuchi
Misono Misumi
Hideki Takeuchi
Takaki Sakurai
Hitoshi Tsuda
Katsumi Tamura
Jiro Ishida
Yoshiyuki Abe
Etsuko Imabayashi
Ichiei Kuji
Hiroshi Matsuda

Background To assess the usefulness of positron emission tomography combined with computed tomography using 18F-fluorodeoxyglucose (FDG PET/CT) for optimizing chemotherapy during neoadjuvant chemotherapy for primary breast cancer.

Keywords:

Taxane
Medical physics
Breast cancer
Radiology
Positron emission tomography
Computed tomography
Anthracycline
Chemotherapy
Medicine
Fluorodeoxyglucose
Pathological
fluorodeoxyglucose positron emission tomography
primary breast cancer
Surgical oncology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations